Henry Chan
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 4
-
- Protein Degradation and Inhibitors 4
- Co-authors
- Juli Feigon (4 shared papers)Yaqiang Wang (2 shared papers)Jiansen Jiang (2 shared papers)Ritwika Basu (1 shared paper)Z. Hong Zhou (1 shared paper)Lukas Sušac (1 shared paper)Donna Reece (3 shared papers)Christine I. Chen (1 shared paper)
- Journals
- Blood (7 papers)Annals of Oncology (3 papers)British Journal of Haematology (2 papers)Journal of Geriatric Oncology (2 papers)Journal of Physiology and Biochemistry (1 paper)
- Partner nations
- New ZealandUnited StatesAustralia
In The Last Decade
Henry Chan
34 papers receiving 406 citations
Peers
Comparison fields: 5 of 74
- Hematology 78
- Aging 11
- Physiology 140
- Emergency Medical Services 38
- Genetics 56
Countries citing papers authored by Henry Chan
This map shows the geographic impact of Henry Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Chan more than expected).
Fields of papers citing papers by Henry Chan
This network shows the impact of papers produced by Henry Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Chan. The network helps show where Henry Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 103 | |
| 2 | 2018 | 50 | |
| 3 | 1996 | 40 | |
| 4 | 2017 | 32 | |
| 5 | 2022 | 24 | |
| 6 | 2017 | 19 | |
| 7 | Socioeconomic disparities in breast cancer screening in Hawaii. | 2007 | 19 |
| 8 | 2019 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2016 | 10 | |
| 13 | 2018 | 8 | |
| 14 | 2016 | 7 | |
| 15 | 1991 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2011 | 4 | |
| 20 | 2019 | 4 |
About Henry Chan
Henry Chan is a scholar working on Oncology, Molecular Biology, Hematology, Pathology and Forensic Medicine and Genetics, having authored 37 papers that have together received 414 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (4 papers), CAR-T cell therapy research (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). The work is most often cited by research in Hematology (78 citations), Aging (11 citations), Physiology (140 citations), Emergency Medical Services (38 citations) and Genetics (56 citations). Henry Chan has collaborated with scholars based in New Zealand, United States and Australia. Frequent co-authors include Juli Feigon, Yaqiang Wang, Jiansen Jiang, Ritwika Basu, Z. Hong Zhou, Lukas Sušac, Donna Reece, Christine I. Chen, Richard J. Milne and Timothy J. Halliday. Their work appears in journals such as Blood, Annals of Oncology, British Journal of Haematology, Journal of Geriatric Oncology and Journal of Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.